Emerging Therapies in Immune Thrombocytopenia

Immune thrombocytopenia (ITP) is a rare autoimmune disorder caused by peripheral platelet destruction and inappropriate bone marrow production. The management of ITP is based on the utilization of steroids, intravenous immunoglobulins, rituximab, thrombopoietin receptor agonists (TPO-RAs), immunosup...

Descripción completa

Detalles Bibliográficos
Autores principales: Audia, Sylvain, Bonnotte, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958340/
https://www.ncbi.nlm.nih.gov/pubmed/33801294
http://dx.doi.org/10.3390/jcm10051004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958340/
https://www.ncbi.nlm.nih.gov/pubmed/33801294
http://dx.doi.org/10.3390/jcm10051004

Ejemplares similares